Skip to content

CTT PHARMACEUTICAL HOLDINGS, INC.: 10-Q filed 2014-11-17

What CTT PHARMACEUTICAL HOLDINGS, INC. reported in its quarterly report filed 2014-11-17 (fiscal Q3 2014): 16 published measures, 44 facts as tagged in accession 0001062993-14-006759.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-17
Fiscal period
fiscal Q3 2014
Accession
0001062993-14-006759 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CTT PHARMACEUTICAL HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-30130,748USD
At 2013-12-310USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-30124,600USD
At 2013-12-3128,906USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-306,148USD
At 2013-12-31-28,906USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-30125,318USD
At 2013-12-310USD
At 2013-09-300USD
At 2012-12-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-43,196USD92
2014-01-01 to 2014-09-30-43,643USD273
2013-07-01 to 2013-09-30-8,473USD92
2013-01-01 to 2013-09-30-11,424USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-25,413USD273
2013-01-01 to 2013-09-300USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2014-01-01 to 2014-09-300USD273
2013-01-01 to 2013-09-300USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30151,892USD273
2013-01-01 to 2013-09-300USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-30-231,478USD
At 2013-12-31-187,835USD

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.01USD/shares92
2014-01-01 to 2014-09-300.01USD/shares273
2013-07-01 to 2013-09-30-0.01USD/shares92
2013-01-01 to 2013-09-30-0.01USD/shares273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-3043,196USD92
2014-01-01 to 2014-09-3043,643USD273
2013-07-01 to 2013-09-308,473USD92
2013-01-01 to 2013-09-3011,424USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-30184,368,022shares
At 2013-12-31184,368,022shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-30131,982USD
At 2013-12-310USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-09-30-3,131USD
At 2013-12-31-2,930USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-43,263USD92
2014-01-01 to 2014-09-30-43,844USD273
2013-07-01 to 2013-09-30-8,762USD92
2013-01-01 to 2013-09-30-11,623USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-3012,946USD92
2014-01-01 to 2014-09-3013,068USD273
2013-07-01 to 2013-09-30975USD92
2013-01-01 to 2013-09-302,960USD273

Inspect the source

Entity
CTT PHARMACEUTICAL HOLDINGS, INC. / CIK 0001035422
Captured
2026-09-20T05:15:10.936Z
SEC response SHA-256
21b0a0ba4c84772224f4978cbe9507956b8d731d5fe56b447e41295eab5239b0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001035422.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))